Beltone opens door to stake sale to strategic investors    Finance Minister begins official 2-day visit to Khartoum    Egypt discovers mid-18th Century shipwreck by Saadana Island in Red Sea    Egypt Sovereign Fund puts Tahrir Complex development into motion    Shoukry hopes Russia resumes flights to Egyptian resorts ahead of Lavrov visit    Egypt's Pyramids suffer embarrassing 3-0 home loss to Morocco's Raja    Recession drama "Nomadland" wins best film at BAFTA awards    AstraZeneca says it had positive meeting with EU over vaccine row    Egypt's Kouka scores twice in Olympiacos win over Panathinaikos    Cleopatra Hospitals, Nahda University sign EGP 7.4m MoU for joint scholarship programme    Power outages hit Saint Vincent island amid volcano tremors    Egyptian-African Relations Committee discusses strengthening Egypt's stance in Africa    IMF gives upward projection for MENA economy to 4% in 2021    JPMorgan studying whether to include Egypt in its emerging-markets government bond index,    SCZone signs EGP 10 billion syndicated loan deal with six banks    Egypt will not allow internal water crisis due to Ethiopian dam: Water Minister    Remittances from Egyptian expats grow 10.6% in 7 months, CBE    Egypt's prosecution says negligence involved in Sohag's deadly train collision    Egypt's hotels, open at half capacity, had 40%-45% occupancy rate in Q1 2021: official    Egypt's Trezeguet injury worries Aston Villa Coach Dean Smith    Cairo Opera House to hold 27 concerts celebrating Ramadan    Iran reports electrical incident at Natanz nuclear site, no casualties    Egypt detects 801 new coronavirus infections; 43 deaths on Saturday    Bibliotheca Alexandrina launches hieroglyphics programme for primary school teachers    Egypt drafts new law prohibiting overseas transfer of historical documents    Egypt takes measures against German company for discrimination against Muslim Egyptian    Egypt, Tunisia agree on Libya support, cooperation on African topics    Arab League, Iraq discuss developments in country, region    Egypt, Sudan reject Ethiopian proposal on data exchange ahead of second filling of GERD    North Sinai's El-Arish Culture Palace reopens after a decade of closure    Ethiopia invites Egypt, Sudan to nominate operators in data exchange on GERD's 2nd filling    Egypt re-elected as Vice-Chair of UN-Habitat Executive Board    Convicted terrorist with links to Islamic State group sentenced to life by Cairo court    Developing countries, including Egypt, will get 1.3 bln vaccine doses by 2021 end, IMF    PMI moves towards a smoke-free transformation, takes part in a webinar on e-cigarettes    Egypt and Uganda sign military intelligence sharing agreement to combat terrorism    Karate Federation celebrates success of Egypt Cup    Zamalek's Shikabala nominated for best goal in CAF Champions League    Egypt's national youth fencing team achieves world glory    Egypt's President warns of grave consequences of water crises in Africa    Saudi Arabia approves opening of Banque Misr branch    Experiencing Egypt's grandeur    Allianz Egypt partners with IGNITE to equip brand ambassadors for 2021 Olympics    Hassan Allam consortium wins contract to manage, operate Grand Egyptian Museum    Enhanced Labs signs Mr. Olympia 2020 "Big Ramy" And His Trainer Dennis James    King Tutankhamun funerary mask is must-see tourist icon: The Telegraph    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Egypt, Ethiopia, Sudan to resume Nile dam talks today    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Saudi Arabia to get AstraZeneca shots in about a week from India
Published in Ahram Online on 25 - 01 - 2021

The Serum Institute of India (SII) will supply Saudi Arabia with 3 million AstraZeneca COVID-19 vaccine doses priced at $5.25 each in about a week on behalf of the British drugmaker, its chief executive told Reuters on Monday.
SII has no immediate plans, however, to divert supplies to Europe, even though AstraZeneca has come under pressure from the EU to deliver more shots after announcing a big cut in shipments due to production problems at a Belgian factory.
SII, the world's biggest vaccine manufacturer, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to make up to a billion doses for poorer countries.
The Indian company supplies doses on behalf of AstraZeneca but is also free to strike its own supply deals.
"We continue to support AstraZeneca wherever they need the support. We are happy to do so," Chief Executive Adar Poonawalla told Reuters in an interview.
"But we have not been asked to supply any more products for Europe because then that would mean supplies to Africa and India would suffer, and we certainly don't want that," he said. "Once I satisfy that I can look at other, richer nations. Six months to a year, that could change."
He said the doses destined for Saudi Arabia would be shipped in a week or 10 days. SII is also supplying South Africa with 1.5 million doses at the same price of $5.25 each on behalf of AstraZeneca.
"We have our hands full, in fact, with the volumes even we need to supply," Poonawalla said. "We have been on time and we are able to supply to all these nations."
The pricing of the deal between South Africa and AstraZeneca has sparked some controversy as it is higher than the $3 a dose that South Africa and other countries on the continent are due to pay for the vaccine under an African Union arrangement.
AstraZeneca has said it will not profit from the vaccine during the pandemic.
Brazil last week received 2 million doses of the vaccine from SII and Poonawalla said it also paid about $5 per dose.
Poonawalla said that SII would raise production of the AstraZeneca vaccine by 30% by the end of March from its current daily output of about 2.4 million doses, once the third and final facility making the shot comes online.
SII also plans to start stockpiling a vaccine candidate from US company Novavax Inc in a few months, despite a fire last week that killed five people and damaged one of its new plants in the western Indian city of Pune.
Poonawalla said SII had no intention of partnering with companies such as Pfizer Inc whose COVID-19 vaccine needs to be stored at about minus 70 Celsius (minus 94 Fahrenheit) as India currently lacks such facilities.
Pfizer, which developed the shot with Germany's BioNTech , told Reuters it would pursue its request for India to approve the vaccine if the government committed to buying shots.
Pfizer was the first drugmaker to seek emergency use authorisation for its vaccine in India in early December but it has yet to be approved.
India's drug regulator says Pfizer officials failed to attend subsequent meetings it had called. The US drugmaker says its officials had not been given enough notice.


Clic here to read the story from its source.